Details
| Stereochemistry | ACHIRAL |
| Molecular Formula | C22H30N2O3 |
| Molecular Weight | 370.4852 |
| Optical Activity | NONE |
| Defined Stereocenters | 0 / 0 |
| E/Z Centers | 0 |
| Charge | 0 |
SHOW SMILES / InChI
SMILES
COC1=CC(CC(=O)NCCCC2=CC=C(C)C(C)=C2)=CC=C1OCCN
InChI
InChIKey=VVMIHZHLNJMAQP-UHFFFAOYSA-N
InChI=1S/C22H30N2O3/c1-16-6-7-18(13-17(16)2)5-4-11-24-22(25)15-19-8-9-20(27-12-10-23)21(14-19)26-3/h6-9,13-14H,4-5,10-12,15,23H2,1-3H3,(H,24,25)
| Molecular Formula | C22H30N2O3 |
| Molecular Weight | 370.4852 |
| Charge | 0 |
| Count |
|
| Stereochemistry | ACHIRAL |
| Additional Stereochemistry | No |
| Defined Stereocenters | 0 / 0 |
| E/Z Centers | 0 |
| Optical Activity | NONE |
Davasaicin is a synthetic derivative of capsaicin, developed at the Korea Research Institute of Chemical Technology. Davasaicin possesses very potent analgesic activity, demonstrated in several animal models, such as phenylbenzoquinone-induced writhing test, tail-flick test in mice and adjuvant arthritic flexion test in rats. When administered topically, davasaicin has an antipruritic effect in the mouse model.
Approval Year
| Substance Class |
Chemical
Created
by
admin
on
Edited
Wed Apr 02 09:57:14 GMT 2025
by
admin
on
Wed Apr 02 09:57:14 GMT 2025
|
| Record UNII |
8V3419G4NR
|
| Record Status |
Validated (UNII)
|
| Record Version |
|
-
Download
| Name | Type | Language | ||
|---|---|---|---|---|
|
Official Name | English | ||
|
Preferred Name | English | ||
|
Systematic Name | English | ||
|
Common Name | English | ||
|
Code | English |
| Classification Tree | Code System | Code | ||
|---|---|---|---|---|
|
NCI_THESAURUS |
C241
Created by
admin on Wed Apr 02 09:57:14 GMT 2025 , Edited by admin on Wed Apr 02 09:57:14 GMT 2025
|
| Code System | Code | Type | Description | ||
|---|---|---|---|---|---|
|
8550
Created by
admin on Wed Apr 02 09:57:14 GMT 2025 , Edited by admin on Wed Apr 02 09:57:14 GMT 2025
|
PRIMARY | |||
|
DTXSID40163729
Created by
admin on Wed Apr 02 09:57:14 GMT 2025 , Edited by admin on Wed Apr 02 09:57:14 GMT 2025
|
PRIMARY | |||
|
177287
Created by
admin on Wed Apr 02 09:57:14 GMT 2025 , Edited by admin on Wed Apr 02 09:57:14 GMT 2025
|
PRIMARY | |||
|
8V3419G4NR
Created by
admin on Wed Apr 02 09:57:14 GMT 2025 , Edited by admin on Wed Apr 02 09:57:14 GMT 2025
|
PRIMARY | |||
|
C83652
Created by
admin on Wed Apr 02 09:57:14 GMT 2025 , Edited by admin on Wed Apr 02 09:57:14 GMT 2025
|
PRIMARY | |||
|
300000034166
Created by
admin on Wed Apr 02 09:57:14 GMT 2025 , Edited by admin on Wed Apr 02 09:57:14 GMT 2025
|
PRIMARY | |||
|
147497-64-1
Created by
admin on Wed Apr 02 09:57:14 GMT 2025 , Edited by admin on Wed Apr 02 09:57:14 GMT 2025
|
PRIMARY | |||
|
CHEMBL328628
Created by
admin on Wed Apr 02 09:57:14 GMT 2025 , Edited by admin on Wed Apr 02 09:57:14 GMT 2025
|
PRIMARY |
| Related Record | Type | Details | ||
|---|---|---|---|---|
|
|
PARENT -> DERIVATIVE |
|
||
|
|
SALT/SOLVATE -> PARENT |
|
| Related Record | Type | Details | ||
|---|---|---|---|---|
|
|
ACTIVE MOIETY |
|